AONC American Oncology Network, Inc.: Market Value

Graphic logo of American Oncology Network (AONC)

As illustrated on the chart, the market value of American Oncology Network (AONC) stands at 0.02, supported by a network of specialized clinics and an automated pharmacy in the US. Demand for drug procurement optimization is driving the expansion of the private medical center support niche. American Oncology Network (AONC) generates revenue by providing IT services and administrative support for physicians, helping them efficiently organize therapy for their patients.

American Oncology Network, Inc. - AONC Market Valuation (period 02/21/2024 - 08/04/2024)

Metric breakdowns and analytics for American Oncology Network Inc (AONC)

- company stock capitalization data:
Fundamental company valuation:American Oncology Network, Inc. AONC
Product sample of American Oncology Network, Inc.

The stability of American Oncology Network (AONC) is based on the consolidation of independent clinics into a single network. The business's market capitalization is calculated as the product of the current share price and the total number of outstanding securities. It is critical for investors to compare this total with the debt load to avoid overpaying for the asset. This metric reflects the market value of the infrastructure that supports patient access to innovative drugs. The dynamics of the business's market capitalization allow for an assessment of how partnerships with pharma behemoths impact the company's valuation.

Competitors of American Oncology Network (AONC)

Market Value BeiGene Ltd ONC|Market Capitalization Halozyme Corp HALO|RVMD - Market Value|Market Valuation AAPG|CG Oncology Corp (CGON) - Market Value|Market Capitalization URGN|BCAX (Bicara Corp) - Market Capitalization|Market Valuation Personalis Corp (PSNL)|Market Capitalization ERAS|Market Capitalization delcath.com (DCTH)|Market Value YmAbs YMAB|AURA: Market Capitalization|Candel Therapeutics, Inc. - Market Capitalization|Accuray Inc. (ARAY) - Market Valuation|SELLAS Life Sciences Group Inc. (SLS) - Market Value|Market Value actuatetherapeutics.com (ACTU)|Market Value Citius Oncology|HURA: Market Value|Market Valuation TARA (Protara)|FATE (Fate Therapeutics Corp) - Market Value|Market Capitalization WHWK (Aadi Bioscience Inc)|TCRX - Market Valuation|CSBR: Market Valuation|XBIT - Market Capitalization|CVM: Market Capitalization|OS Therapies Inc - Market Value|RADX (radiopharmtheranostics.com) - Market Capitalization|Market Value Artiva Biotherapeutics, Inc. ARTV|Market Capitalization ANL|Market Value VERU (Veru)|Market Capitalization TPST (tempesttx.com)|Xilio - Market Value|RENB - Market Value|Market Value MURA (muraloncology.com)|Kairos Pharma Inc (KAPA) - Market Value|OnKure (OKUR) - Market Capitalization|Market Value w2.cytomed.sg|Curis (CRIS) - Market Capitalization|Market Value Apollomics, Inc. (APLM)|Market Valuation tharimmune.com THAR|Market Capitalization ADVB (Advanced Biomed)|GNPX: Market Capitalization|calidibio.com - Market Capitalization|Market Value Sunshine Biopharma|XBIO: Market Capitalization|salariuspharma.com - Market Value|Market Value Kitov Pharma|BGNE (BeiGene) - Market Value|Market Valuation CKPT (Checkpoint Therapeutics, Inc)|ELEV - Market Value|Market Capitalization ICAD (iCAD Inc.)|Ikena (IKNA) - Market Value|NTBL: Market Valuation|VIRX - Market Capitalization|MorphoSys Corp (MOR) - Market Value|Market Valuation NAYA Bio|Market Value Ascentage Pharma Group